VIR

Biotechnology Edmund Ingham GILD GILD:CA Uncategorized VIR

Vir Biotechnology: Up On Prostate Data And Astellas Deal – I’m (Long-Term) Bullish

Feb 24, 2026

ALPMF ALPMY Biotechnology Uncategorized VIR

Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset

Feb 23, 2026

vir-biotechnology-issues-license-to-norgine-to-market-hepatitis-d-candidate

Biotechnology Uncategorized VIR

Vir Biotechnology issues license to Norgine to market hepatitis D candidate

Dec 16, 2025

Comments eenevski/iStock via Getty Images Vir Biotechnology (VIR) has granted Norgine Pharma UK an exclusive...